|Age:||18 years or older|
|Keywords:||hemophilia B, blood clotting disorder|
|Type:||Genetic study, Phase 3|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
150 previous exposure days of treatment with factor IX protein